Myeloid TGF-β signaling contributes to colitis-associated tumorigenesis in mice

Carcinogenesis

Volumn 34, Issue 9, 2013, Pages 2099-2108

  Li, Jingyi ^a   Liu, Yun ^a   Wang, Boshi ^a   Xu, Yingqian ^a   Ma, Aihui ^a   Zhang, Feng ^a   Ge, Chao ^a   Yang, Zhaojuan ^a   Li, Jinjun ^a   Liu, Yongzhong ^a  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER GROWTH FACTOR; CD103 ANTIGEN; CD4 ANTIGEN; CELL NUCLEUS ANTIGEN; CHEMOKINE RECEPTOR CCR2; COLONY STIMULATING FACTOR 1; CYCLIN D1; GAMMA INTERFERON; GLYCOPROTEIN P 15095; INTERLEUKIN 10; INTERLEUKIN 17; INTERLEUKIN 6; STAT3 PROTEIN; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; BONE MARROW CELL; CANCER SIZE; CANCER STAGING; CANCER SUSCEPTIBILITY; CANCER TISSUE; CD4+ T LYMPHOCYTE; CELL PROLIFERATION; COLITIS; COLON ADENOMA; COLON CANCER; COLON CARCINOGENESIS; COLON MUCOSA; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOWN REGULATION; FEMALE; GENE DELETION; LAMINA PROPRIA; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; REGULATORY T LYMPHOCYTE; SIGNAL TRANSDUCTION; TUMOR MICROENVIRONMENT;

ANIMALS; CARCINOGENESIS; COLITIS; COLON; HUMANS; INFLAMMATION; INTESTINAL MUCOSA; MICE; MYELOID CELLS; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84887010968     PISSN: 01433334     EISSN: 14602180     Source Type: Journal    
DOI: 10.1093/carcin/bgt172     Document Type: Article

References (40)

1. Eaden, J.A. et al. (2001) The risk of colorectal cancer in ulcerative colitis: a meta-analysis. Gut, 48, 526-535.
2. Itzkowitz, S.H. et al. (2004) Inflammation and cancer IV. Colorectal cancer in inflammatory bowel disease: the role of inflammation. Am. J. Physiol. Gastrointest. Liver Physiol., 287, G7-17.
3. Coussens, L.M. et al. (2002) Inflammation and cancer. Nature, 420, 860-867.
4. Karin, M. et al. (2005) NF-kappaB: linking inflammation and immunity to cancer development and progression. Nat. Rev. Immunol., 5, 749-759.
5. Podolsky, D.K. (2002) Inflammatory bowel disease. N. Engl. J. Med., 347, 417-429.
6. Ishikawa, T.O. et al. (2011) Cox-2 deletion in myeloid and endothelial cells, but not in epithelial cells, exacerbates murine colitis. Carcinogenesis, 32, 417-426.
7. Imtiyaz, H.Z. et al. (2010) Hypoxia-inducible factor 2alpha regulates macrophage function in mouse models of acute and tumor inflammation. J. Clin. Invest., 120, 2699-2714.
8. Greten, F.R. et al. (2004) IKKbeta links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell, 118, 285-296.
9. Popivanova, B.K. et al. (2008) Blocking TNF-alpha in mice reduces colorectal carcinogenesis associated with chronic colitis. J. Clin. Invest., 118, 560-570.
10. Neibergs, H.L. et al. (2002) Genetic profiling of colon cancer. J. Surg. Oncol., 80, 204-213.
11. Biswas, S. et al. (2004) Transforming growth factor beta receptor type II inactivation promotes the establishment and progression of colon cancer. Cancer Res., 64, 4687-4692.
12. Becker, C. et al. (2004) TGF-beta suppresses tumor progression in colon cancer by inhibition of IL-6 trans-signaling. Immunity, 21, 491-501.
13. Kim, B.G. et al. (2006) Smad4 signalling in T cells is required for suppression of gastrointestinal cancer. Nature, 441, 1015-1019.
14. Otsuka, M. et al. (2010) Distinct effects of p38alpha deletion in myeloid lineage and gut epithelia in mouse models of inflammatory bowel disease. Gastroenterology, 138, 1255-1265, 1265.e1.
15. Novitskiy, S.V. et al. (2012) Deletion of TGF-ß signaling in myeloid cells enhances their anti-tumorigenic properties. J. Leukoc. Biol., 92, 641-651.
16. Liu, Y. et al. (2008) A critical function for TGF-beta signaling in the development of natural CD4+CD25+Foxp3+ regulatory T cells. Nat. Immunol., 9, 632-640.
17. Ouyang, W. et al. (2010) Transforming growth factor-beta signaling curbs thymic negative selection promoting regulatory T cell development. Immunity, 32, 642-653.
18. Veldhoen, M. et al. (2006) TGFbeta1, a "Jack of all trades": the link with pro-inflammatory IL-17-producing T cells. Trends Immunol., 27, 358-361.
19. Veldhoen, M. et al. (2006) Signals mediated by transforming growth factorbeta initiate autoimmune encephalomyelitis, but chronic inflammation is needed to sustain disease. Nat. Immunol., 7, 1151-1156.
20. Veldhoen, M. et al. (2008) Transforming growth factor-beta 'reprograms' the differentiation of T helper 2 cells and promotes an interleukin 9-producing subset. Nat. Immunol., 9, 1341-1346.
21. Chytil, A. et al. (2002) Conditional inactivation of the TGF-beta type II receptor using Cre:Lox. Genesis, 32, 73-75.
22. Ijichi, H. et al. (2011) Inhibiting Cxcr2 disrupts tumor-stromal interactions and improves survival in a mouse model of pancreatic ductal adenocarcinoma. J. Clin. Invest., 121, 4106-4117.
23. Clausen, B.E. et al. (1999) Conditional gene targeting in macrophages and granulocytes using LysMcre mice. Transgenic Res., 8, 265-277.
24. Fukata, M. et al. (2005) Toll-like receptor-4 is required for intestinal response to epithelial injury and limiting bacterial translocation in a murine model of acute colitis. Am. J. Physiol. Gastrointest. Liver Physiol., 288, G1055-G1065.
25. Neufert, C. et al. (2007) An inducible mouse model of colon carcinogenesis for the analysis of sporadic and inflammation-driven tumor progression. Nat. Protoc., 2, 1998-2004.
26. Erdman, S.E. et al. (2005) CD4+CD25+ regulatory lymphocytes induce regression of intestinal tumors in ApcMin/+ mice. Cancer Res., 65, 3998-4004.
27. Dunn, G.P. et al. (2004) The immunobiology of cancer immunosurveillance and immunoediting. Immunity, 21, 137-148.
28. Atreya, R. et al. (2008) Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer. Curr. Drug Targets, 9, 369-374.
29. Fukata, M. et al. (2007) Toll-like receptor-4 promotes the development of colitis-associated colorectal tumors. Gastroenterology, 133, 1869-1881.
30. Takedatsu, H. et al. (2008) TL1A (TNFSF15) regulates the development of chronic colitis by modulating both T-helper 1 and T-helper 17 activation. Gastroenterology, 135, 552-567.
31. Strober, W. et al. (2011) Proinflammatory cytokines in the pathogenesis of inflammatory bowel diseases. Gastroenterology, 140, 1756-1767.
32. Mottet, C. et al. (2003) Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J. Immunol., 170, 3939-3943.
33. Bettelli, E. et al. (2006) Reciprocal developmental pathways for the generation of pathogenic effector TH17 and regulatory T cells. Nature, 441, 235-238.
34. Barbi, J. et al. (2013) Metabolic control of the Treg/Th17 axis. Immunol. Rev., 252, 52-77.
35. Pankov, R. et al. (2002) Fibronectin at a glance. J. Cell Sci., 115, 3861-3863.
36. Van Ginderachter, J.A. et al. (2006) Classical and alternative activation of mononuclear phagocytes: picking the best of both worlds for tumor promotion. Immunobiology, 211, 487-501.
37. Sica, A. et al. (2006) Tumour-associated macrophages are a distinct M2 polarised population promoting tumour progression: potential targets of anti-cancer therapy. Eur. J. Cancer, 42, 717-727.
38. Chow, M.T. et al. (2012) Inflammation and immune surveillance in cancer. Semin. Cancer Biol., 22, 23-32.
39. Grivennikov, S. et al. (2009) IL-6 and Stat3 are required for survival of intestinal epithelial cells and development of colitis-associated cancer. Cancer Cell, 15, 103-113.
40. Bollrath, J. et al. (2009) gp130-mediated Stat3 activation in enterocytes regulates cell survival and cell-cycle progression during colitis-associated tumorigenesis. Cancer Cell, 15, 91-102.